Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR ANXIETY AND DEPRESSION PRIMARY PREVENTION IN YOUTH

NCT07472894 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Patras
Phase
Not applicable
Started
2027-09-01
Last updated
2026-04-14

Condition(s) studied

Anxiety Depression

Investigational drug(s) / intervention(s)

Peer-mentoring behavioral interventionHealth Education

Peer-mentoring behavioral intervention: The intervention' s content will be based on existing evidence-based interventions, namely the Mindfulness-based Stress Reduction program which enhances stress management and the Positive Youth Development Framework which strengthens social and emotional skills and facilitates social competence.

Health Education: Health education sessions delivered by professionals focusing on stress management and social skills

Study summary

The goal of this clinical trial will be to evaluate the efficacy of an AI-informed peer-mentoring program to improve stress management and social skills and reduce the risk of depressive and anxiety symptoms in healthy adolescents (12-18 years old) and young adults (18-25 years old). The main question it aims to answer is whether the peer-mentoring behavioral intervention will achieve the desired behavioral changes and reduce the emergence of anxiety and depression symptoms. Researchers will compare the AI-informed peer-mentoring behavioral intervention program with a standard peer-mentoring program and a standard health educational program. Some study participants will be trained to be peer mentors and subsequently they will be paired with slightly younger mentees and they will attend shared activities for an academic year

Eligibility

Sex
ALL
Min age
12 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria: Healthy individuals aged 12-25 yrs old - Exclusion Criteria: Chronic mental health conditions, severe cognitive or communication deficits \-

Primary outcome measure(s)

  • Perceived Stress Scale (PSS-10) — From enrollment to the end of the intervention at 6 months
    Assessment of stress levels
  • Revised Children Anxiety and Depression Scale (RCADS-25) — From enrollment to intervention completion at 6 months
    Assessment of anxiety and depressive symptoms in adolescents
  • Depression Anxiety Stress Scale (DASS-21) — From enrollment to study completion at 6 months
    Assessment of anxiety, depressive and stress symptoms in young adults
  • Depression Anxiety Stress Scale Youth (DASS-Y) — From enrollment to study completion at 6 months
    Assessment of anxiety, depressive and stress symptoms in adolescents
  • KIDSCREEN-27 Social functioning sub-scale — From enrollment to study completion at 6 months
    Assessment of social functioning
  • SF36 Social functioning sub-scale — From enrollment to study completion at 6 months
    Assessment of social functioning

Trial sites (2)

FacilityCityRegionStatus
University Hospital of Patras Pátrai Greece
Modena Health Authority Modena Italy
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07472894 on ClinicalTrials.gov ↗ ← All trials in Italy